tavilermide inn developmental code name selective cyclic tripeptide partial agonist trka class drugs sometimes referred nerve growth factor ngf tavilermide first synthesized burgess coworkers texas university intention producing trka development mimetogen pharmaceuticals ophthalmic eye drop solution treatment dry eyes phase iii clinical trials indication tavilermide currently evaluated two multicenter phase iii clinical studies united states treatment dry eye tavilermide also phase clinical trials treatment glaucoma studies httpsenwikipediaorgwikitavilermide